Dual-Purpose pill: roxadustat may fight both anemia and muscle wasting in dialysis
NCT ID NCT07162090
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether roxadustat, a drug currently used to treat anemia in kidney disease, can also improve sarcopenia (muscle loss) in patients on hemodialysis. Sixty adults with end-stage kidney disease and anemia will receive either roxadustat or standard erythropoietin. Researchers will measure changes in muscle strength, size, and walking speed over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Roxadustat (a pill that helps the body produce more red blood cells and may affect muscle health)
- What this could lead to
- If it works, roxadustat could offer a way to treat both anemia and muscle loss in dialysis patients with a single pill.
- What could go wrong
- This is a small, early-phase study with only 60 participants, so results may not apply to everyone. Roxadustat is already used for anemia, but its effect on muscle loss is unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Calf power may hold the key to healthy aging – a study investigates
- Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
- Squats may stave off muscle loss in older adults — a trial puts it to the test
- Can a new drug combo help kidney transplants last longer?
- Meditation and exercise may combat muscle wasting in dialysis patients
- Ultrasound may fine-tune fluid balance in dialysis patients — a trial puts it to the test